Skip to main content

3 articles related to "Linc01116"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 08 Mar 2021

LINC01116 Promotes Doxorubicin Resistance in Osteosarcoma by Epigenetically Silencing miR-424-5p and Inducing Epithelial-Mesenchymal Transition

in Pharmacology of Anti-Cancer Drugs

Ran Li
Qing Ruan
Jia Zheng
Butian Zhang
Hongliang Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.632206

4,806 views
35 citations

Review

Published on 14 Oct 2021

Promising Advances in LINC01116 Related to Cancer

in Molecular and Cellular Oncology

Yating Xu
Xiao Yu
Menggang Zhang
Qingyuan Zheng
Zongzong Sun
Yuting He
Wenzhi Guo

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2021.736927

5,112 views
29 citations

Original Research

Published on 14 Sep 2022

Development of a novel hypoxia-immune–related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer

in Cancer Immunity and Immunotherapy

Likun Luan
Youguo Dai
Tao Shen
Changlong Yang
Zhenpu Chen
Shan Liu
Junyi Jia
Zhenhui Li
Shaojun Fang
Hengqiong Qiu

Frontiers in Immunology

doi 10.3389/fimmu.2022.951455

6,881 views
21 citations